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The gastrointestinal tract (GIT) is home to a highly diverse and dynamic ecosystem comprising of a complex microbial community termed the gut microbiota. The statistics of the microbiota or microbiome are remarkable. There are at least 10 times more bacteria in the gut than human cells (1014 versus 1013) which contain 150-fold more genes than the human genome (Nature 2010;464:59-65). These bacteria co-evolved with humans and deliver a number of functions that are not provided by the human genome, for example, the synthesis of biotin and vitamin K. The gut microbiota also has significant effects on the regulation of host immune response, metabolism, bone mineralization and even behaviour. Gut bacteria are recognized by a range of pattern recognition receptors including Toll-like receptors (TLR) which in turn signal and modulate the innate immune system. The major downstream pathway of TLR signalling is via the common adapter molecule MyD88. The authors therefore hypothesized that gut flora might regulate host gene expression via MyD88-dependent mechanisms (Annu Rev Physiol. 2012;74:177-98). This study had two aims. First, to determine the host signalling pathways induced by the microbiota, and secondly, to determine if these are dependent on MyD88 and TLRs. The majority of studies to date have focused on the colon. However, the structure and function of the GIT varies markedly along its length. For example, the small intestine has villi, whereas the colon does not. Nutrient absorption occurs in the duodenum and jejunum. The ileum has the most reactive immune response, and the colon is a fermentation chamber producing short chain fatty acids. Bacterial abundance also varies along the length of the GIT, with the duodenum containing 104 cells/g, whereas the colon contains 1012/g (Annu Rev Microbiol 2009;63:269-90). In this study the authors analysed the microbiota from each intestinal segment separately. 

The authors undertook transcriptional profiling studies of GIT tissue and epithelial cells isolated from C57BL/6 mice raised in conventional and germ-free conditions. MyD88 -/- mice, both conventionally raised and germ-free, were also studied. RNA labelling, microarray hybridisation and scanning were performed using Affymetrix MoGene 1.0 ST microarray chips with detailed bioinformatic analysis. Key findings from the microarray studies where confirmed by RT-PCR. Microbiota community profiling was also undertaken using 16S rRNA sequencing, analysing 12 segments of gut contents, from the duodenum to the distal colon. 

Global transcriptional profiles of duodenum, jejunum, ileum and colon, of conventionally raised and germ free wildtype and MyD88 -/- mice, were obtained from 77 microarray hybridisations of whole gut tissue. In the small intestine between 2844 and 5653 genes were regulated by the gut microbiota depending on the segment under study. The majority of these genes concerned the adaptive and innate immune response. The authors hypothesized that mucosal lymphocytes were the source of microbiota-modulated genes associated with adaptive immunity. In the duodenum, genes associated with energy harvesting, mitochondria and peroxisomes were down-regulated. In contrast to the small intestine, fewer genes (2124) were regulated in the colon, the majority of which were metabolic genes. The authors speculate that the lower proportion of microbiota-regulated genes in the colon, may be due to the thick mucus layer preventing access of bacteria to the epithelium. Of interest, genes associated with cholesterol biosynthesis were amongst the top microbiota responding targets within the jejunum, ileum and colon.

It was anticipated that MyD88 would have a major influence on gene expression, given its role in mediating the majority of TLR signalling. However, MyD88 was only found to influence gene expression in the jejunum; it had little effect in the duodenum, ileum or colon. Furthermore, MyD88-dependent responses were independent of the gut microbiota. The few genes that were dependent on MyD88 were located in the colon. 

Expression levels of immunoglobulin genes were regulated by the microbiota in all GIT segments, but were independent of MyD88. Consistent with this observation, increased chemokine expression was found in both whole gut samples and isolated epithelial cells from conventionally raised mice when compared to germ-free mice. There was also an upregulation of genes involved in barrier function, including proline-rich protein 1A and 1B and MUC 2, MUC4 and MUC13, in both whole gut tissue and isolated epithelial cells. 

Anti-viral genes were upregulated within the colon, but not small intestine of MyD88 -/- mice. This result is surprising at first sight, as antiviral pathways are not usually dependent on MyD88. However, a number of studies have indicated that experimental viral infection mortality is higher in MyD88 deficient animals (Science 2008;321:691-6). The authors went on to screen for 15 viruses and found that the MyD88-deficient mice were infected by murine norovirus – an infection common in animal facilities. The authors concluded that the increased expression of anti-viral genes was in response to murine norovirus infection.

REG3β and REG3γ are secreted by Paneth and absorptive cells, and play a major role in maintaining the sterility of the inner mucus layer, adjacent to the apical surface of the epithelium (Science. 2011;334:255-8). Expression of both these antimicrobial peptides was increased by the gut microbiota. Interestingly, this expression was dependent on MyD88 in the colon, but not the small intestine. Expression of genes involved in the synthesis of reactive oxygen and nitrogen species, with potent antimicrobial actions (NOX1, NOS2 and DUOX2), were increased within the microbiota colonised ileum, but were found to be MyD88-independent. 

The effect of MyD88 on the composition of the microbial communities along the length of the gut was assessed using 454-based pyrosequencing of 16S rRNA. MyD88 deficient mice were found to have an increase in the abundance of segmented filamentous bacteria (SFB). These are clostridia related gram positive bacteria that promote immune responses in mice, particularly the induction of TH17 lymphocytes (DNA Res 2011;18:291-303). They are not known to be important in humans. The authors speculate that their location on the surface of the epithelial cells might make them particularly sensitive to MyD88-sensitive antibacterial peptides.

Detailed bioinformatics analysis of microbiota diversity, along the length of the intestine, demonstrated that MyD88 positive (wildtype) and MyD88 deficient mice have different bacterial communities. Notably, there was greater inter-mouse variation in MyD88-/- animals. The authors speculate that this variation may be due to MyD88 dependent increases in REG3β and REG3γ within the colon, but make the point that further experiments are required.

Comment
The intestinal microbiota provides many benefits for its host including energy uptake and development of mucosal and systemic immunity. The host molecules that recognise this bacterial community are the TLRs, and their localisation at the interface between the microbiota and the molecular machinery of host cells (including the adaptor molecule MyD88) indicate that they may be key players in this valuable relationship. This recent study by Larsson et al, indicates that while the microbiota induce wholesale changes in host gene expression, the majority of these changes do not appear to require MyD88. 

The apparent lack of MyD88-mediated changes in host gene expression maybe age dependent. Birth marks the transition from a sterile gut to one that is microbe dense, and corresponds to a critical time window in which dynamic microbiota-host interactions profoundly influence health. Supporting evidence comes from Chassin et al. who found that the TLR-4-mediated transcriptional activation of intestinal epithelial cells was observed in mice immediately after birth and was induced by oral ingestion of LPS. This resulted in a post-transcriptional down-regulation of epithelial IRAK1 protein expression (MyD88-interacting molecule), and subsequently protected the host from further bacteria-induced epithelial damage (Cell Host & Microbe 2010;8:358-368). Thus, studies examining microbiota-induced MyD88 signalling during neonatal developmental stages may reveal more extensive regulation of host gene expression in the GIT. 

While Larsson et al used whole tissue MyD88-/- mice to examine host gene expression, a recent study has examined these responses using a targeted deletion of MyD88 in intestinal epithelial cells. Loss of epithelial MyD88 expression resulted in down-regulation of polymeric immunoglobulin receptor, mucin 2 and the antimicrobial peptides RegIIIγ and Defa-rs1 (Mucosal Immunol 2012;5:501-512). Comparison of these two studies suggests that MyD88 may play a differential role in regulating microbiota-induced host innate gene expression in the context of different cellular compartments (whole tissue vs. epithelial), particularly immunoglobulin and mucin responses. However, it should be noted that both studies show that MyD88 deletion resulted in increased numbers of mucus-associated bacteria, which may be due, in part, to impaired anti-microbial responses (RegIIIγ). A previous study also suggests that cellular compartmentalisation of the MyD88 response is required for maintenance of host defence and in the prevention deleterious inflammatory responses. MyD88-dependent activation of myeloid cells was required for the development of chronic intestinal inflammation while epithelial cell MyD88 signals were insufficient to induce intestinal inflammation in the absence of an MyD88-competent myeloid compartment (Gastroenterology 2010;139:519-529). 

A number of papers, including the study by Larssen et al, indicate that genetic defects in various innate immune molecules impacts significantly on overall microbiota composition along the length of the GIT. Mice deficient in IgA have elevated levels of SFB (PNAS 2004;101:1981-1986). This is also described in this study, although notably this did not correlate to differences in immunoglobulin expression. Moreover, NLRP6-/- mice become colonised with a microbiota that can exacerbate colitis in wildtype mice after microbiota transfer (Cell 2011;145:745-757).  TLR5-/- mice also have alterations in their microbiota community structure; differing by over 100 bacterial phylotypes, when compared to wildtype controls (Science 2010;328:255-258). Indeed, differences in the microbiota in response to MyD88 deficiency has already shown increases in the Rikenellaceae and Porphyromonadaceae bacterial families (Nature 2008;455:1109-1113). This is in agreement with the Larssen study, which also reports a shift in bacterial diversity. While host genetics appears to have a strong influence on overall microbiota ecology, other exogenous factors; including diet, antibiotics and maternal microbiota transmission, can also significantly alter the microbiota community.  Most recently, examination of microbiota composition under homeostatic conditions indicates that MyD88 and other specific TLR have a minimal impact on overall community structure. The authors hypothesise that microbiota differences observed between MyD88-/- and wildtype mice in previous papers may not be due to impaired innate signalling. They suggest that long-term breeding of mouse colonies is actually the major factor modulating overall microbiota composition (J Ex Med 2012;209:1445-1456). These new data suggest that caution must be applied, paying particular attention to husbandry and parental lineages, when interpreting microbiota analysis of mutant and wildtype mice.
It is well known that the microbiota are critically important for host metabolism (Science 2012; 336:1262-1267). The study by Larssen et al, also indicates that metabolism related genes, including lipid and fatty acid metabolism, are regulated by the microbiota throughout the entire GIT. Interestingly, they also found that genes related to cholesterol biosynthesis were differentially regulated depending on the site within the GIT. This suggests that microbial community differences or changes in overall bacterial levels, that are also found along the length of the GIT, may induce these metabolic changes. Although they examined the contribution of microbiota-MyD88 signalling for genes involved in immune responses, they did not report this for metabolism related gene-sets. Previously, mice deficient in TLR5-/- have been shown to develop features of metabolic syndrome, which correlated with alterations in the microbiota (Science 2010;328:255-258). These data highlight that deficiencies in the host innate immune system, and interactions with the microbiota, may contribute to metabolic disease. Further studies are required to determine if this is specifically via modulation of host metabolism genes. 

The study by Larssen at al, emphasises the significant contribution of the microbiota to host gene expression. In their study, they comprehensibly examine these responses with respect to the different GIT compartments, rather than focusing on the small intestine or colon, which the majority of previous studies have done. Variations between the colon, ileum, jejunum and duodenum may correlate with differences in microbiota densities and community structure that are also found to vary among these sites.  Interestingly, although MyD88 represents the major adaptor molecule required for signalling via TLR activation, after recognition of microbial products, it does not appear to play a major role in the regulation of host gene expression. However, exceptions include the antimicrobial genes RegIIIγ and RegIIIβ, which may also correlate to the elevated levels of SFB in MyD88-/- mice.  This study also adds to the findings that absence of innate signalling molecules can lead to alterations in overall microbiota ecology, although recent findings suggest that care should now be taken when analysing the microbiota of mutant and wildtype mice. 

Overall this intriguing study emphasizes the complexes relationships with the gut microbiota and host, and highlights that the mechanisms, whereby the gut flora regulate host gene expression, are not understood. Other molecular pathways independent of MyD88 must clearly be involved, and further investigation is required. Once these pathways are defined the door will be opened for new therapies based on manipulation of gut microbiota. 
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